RiverVest Venture Fund IV, L.P. is 10% Owner at Xilio Therapeutics, Inc. (XLO). They have made 2 open-market trades across 2 companies since 2021, most recently 2021-10-26.
CIK 0001725443
2 open-market purchases totalling $7.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.